Junctophilin-2 prevents MURF1-mediated junctin ubiquitination and proteasome-dependent degradation to promote cardiomyocyte survival 4606

Abstract Description Junctophilin-2 (JP2) is required for the development, maturation and integrity of t-tubule system and Ca2+ regulation in cardiomyocytes. This study investigated if and how JP2 maintained junctin to prevent cardiomyocyte death under stress. Cardiomyocytes were exposed to different stress. Adenoviral vectors were used to manipulate expression of JP2 and junctin. Transverse aortic constriction (TAC)-induced heart failure models were created. Myocardial function was assessed by echocardiography. Stress decreased JP2 expression and concomitantly reduced junctin protein expression in cardiomyocytes. JP2 over-expression preserved junctin protein levels and attenuated cytosolic Ca2+ and apoptosis under stress. Notably, junctin over-expression prevented cardiomyocyte death under stress, whereas knockdown of junctin offset the protective effects conferred by JP2 over-expression. Mechanistically, JP2 blocked MURF1-junctin interaction, thereby preventing junctin ubiquitination and subsequent proteasome-dependent degradation. Mass spectrometry analysis identified multiple ubiquitination sites on junctin protein and the non-ubiquitinated junctin mutant was resistant to degradation. In TAC-induced heart failure model, transgenic over-expression of JP2 prevented junctin-MURF1 interaction and junctin ubiquitination and increased junctin protein levels. In summary, this study uncovers an unrecognized role of JP2 in preventing junctin ubiquitination and degradation and protecting cardiomyocytes Funding Sources This study was supported by the Heart & Stroke Foundation of Canada (G-17-0018361 to T.P.), the Natural Sciences and Engineering Research Council of Canada (RGPIN-2017-04768 to T.P.), the Doctoral Innovation Projects of Jiangsu Province (Grant no. KYCX17_1816 to X.J.), the National Heart, Lung, and Blood Institute (R01 HL130346, HL157781, HL157741 L.S.S.). Topic Categories Cellular Adhesion, Migration, and Inflammation (CAM)

Authors

Publication Details

Journal
The Journal of Immunology
Published
2025-11-01
DOI
https://doi.org/10.1093/jimmun/vkaf283.2266
Primary Topic
Congenital heart defects research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Junctophilin-2 prevents MURF1-mediated junctin ubiquitination and proteasome-dependent degradation to promote cardiomyocyte survival 4606

Xiaoyun Ji
The Journal of Immunology
Congenital heart defects research
article

Junctophilin-2 prevents MURF1-mediated junctin ubiquitination and proteasome-dependent degradation to promote cardiomyocyte survival 4606

Xiaoyun Ji
article en

Abstract

Abstract Description Junctophilin-2 (JP2) is required for the development, maturation and integrity of t-tubule system and Ca2+ regulation in cardiomyocytes. This study investigated if and how JP2 maintained junctin to prevent cardiomyocyte death under stress. Cardiomyocytes were exposed to different stress. Adenoviral vectors were used to manipulate expression of JP2 and junctin. Transverse aortic constriction (TAC)-induced heart failure models were created. Myocardial function was assessed by echocardiography. Stress decreased JP2 expression and concomitantly reduced junctin protein expression in cardiomyocytes. JP2 over-expression preserved junctin protein levels and attenuated cytosolic Ca2+ and apoptosis under stress. Notably, junctin over-expression prevented cardiomyocyte death under stress, whereas knockdown of junctin offset the protective effects conferred by JP2 over-expression. Mechanistically, JP2 blocked MURF1-junctin interaction, thereby preventing junctin ubiquitination and subsequent proteasome-dependent degradation. Mass spectrometry analysis identified multiple ubiquitination sites on junctin protein and the non-ubiquitinated junctin mutant was resistant to degradation. In TAC-induced heart failure model, transgenic over-expression of JP2 prevented junctin-MURF1 interaction and junctin ubiquitination and increased junctin protein levels. In summary, this study uncovers an unrecognized role of JP2 in preventing junctin ubiquitination and degradation and protecting cardiomyocytes Funding Sources This study was supported by the Heart & Stroke Foundation of Canada (G-17-0018361 to T.P.), the Natural Sciences and Engineering Research Council of Canada (RGPIN-2017-04768 to T.P.), the Doctoral Innovation Projects of Jiangsu Province (Grant no. KYCX17_1816 to X.J.), the National Heart, Lung, and Blood Institute (R01 HL130346, HL157781, HL157741 L.S.S.). Topic Categories Cellular Adhesion, Migration, and Inflammation (CAM)

The Journal of ImmunologyVol. 214(Supplement_1)
Government of Jiangsu Province, Natural Sciences and Engineering Research Council of Canada, National Heart, Lung, and Blood Institute
Openalex Percentile: Top 68%
Congenital heart defects research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Junctophilin-2 prevents MURF1-mediated junctin ubiquitination and proteasome-dependent degradation to promote cardiomyocyte survival 4606 — Xiaoyun Ji · The Journal of Immunology (2025) | TGRS Research Map | TGRS